The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against ...

Abstract: Offshore wind turbine components endure high mechanical and thermal stress due to fluctuating wind conditions and harsh marine environments, but lack coordinated stress management due to the ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Get the latest on Atea Pharmaceuticals’ Q3 2025 earnings, HCV Phase III progress, hepatitis E pipeline expansion, and key financial updates.

If you haven’t done so already, we encourage you to determine your short- and long-term career goals to identify your postdoc training needs. Creating an IDP is a great way to do this, and when you’re ...

The whole project is expected to be complete in Fall 2029. The project started in 2017. Schumer offers plan to end shutdown on Senate floor NCAA finds 6 players from 3 schools involved in fixing games ...

CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the ...

- Robust responses observed in heavily pre-treated patients with a 68% ORR for 1.6 mg/kg in second-line setting -Compelling activity in patients with baseline brain metastases (n=32), including an 80% ...